AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego
Summary
Moreover, AtomVie complements its manufacturing and logistics expertise with a high-standard quality management system and global regulatory support. Mr. Ashique was an instrumental part of CPDCs success for over eight years with more than 20 years of extensive expertise in radiochemistry, development, and GMP manufacturing of ready-to-use radiopharmaceuticals.With its world-class employees and its in-depth experience in the radiopharmaceutical industry, AtomVie empowers the development of next-generation radiotherapeutics worldwide.AtomVie, incorporated in late 2021, is a global leading CDMO for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals and figures as the most recent spinout from the CPDC. Founded in 2008, the CPDC is a CECR (Centre of Excellence for Commercialization and Research) located at McMaster University in Hamilton, Ontario, Canada. The CPDC was created with the long-time support from the NCE (Networks of Centres of Excellence), McMaster University and the OICR (Ontario Institute for Cancer Research). To learn more about CPDC, visit www.imagingprobes.ca or contact: info@imagingprobes.ca.Avego, founded in 2015 by former healthcare entrepreneurs, is a multi-strategy healthcare-focused investment firm with offices in Georgia and New York.